Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Spiradoline

From Wikipedia, the free encyclopedia
A κ-opioid agonist drug
Pharmaceutical compound
Spiradoline
Clinical data
Routes of
administration
N/A
ATC code
  • none
Identifiers
  • 2-(3,4-Dichlorophenyl)-N-methyl-N-[(5R,7S,8S)-7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl] acetamide
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC22H30Cl2N2O2
Molar mass425.39 g·mol−1
3D model (JSmol)
  • CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=CC(=C(C=C4)Cl)Cl
  • InChI=1S/C22H30Cl2N2O2/c1-25(21(27)14-16-5-6-17(23)18(24)13-16)19-7-9-22(8-4-12-28-22)15-20(19)26-10-2-3-11-26/h5-6,13,19-20H,2-4,7-12,14-15H2,1H3/t19-,20-,22-/m0/s1 ☒N
  • Key:NYKCGQQJNVPOLU-ONTIZHBOSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Spiradoline (U-62066) is a drug which acts as a highly selectiveκ-opioidagonist.[1] It hasanalgesic,[2]diuretic,[3] andantitussive effects,[4] and produces subjective effects in animals similar to those ofketazocine andalazocine.[5] The main effect in humans issedation, along with analgesic and diuretic effects, but significant side effects such asdysphoria andhallucinations have stopped it from being used clinically.[6]

See also

[edit]

References

[edit]
  1. ^Vonvoigtlander PF, Lewis RA (July 1988). "Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid".The Journal of Pharmacology and Experimental Therapeutics.246 (1):259–62.PMID 2839665.
  2. ^Kunihara M, Ohyama M, Nakano M, Hayashi S (1989). "Analgesic activity of spiradoline mesylate (U-62,066E), a kappa opioid agonist in mice".Life Sciences.45 (13):1191–8.doi:10.1016/0024-3205(89)90508-0.PMID 2796604.
  3. ^Yamada K, Imai M, Yoshida S (January 1989). "Mechanism of diuretic action of U-62,066E, a kappa opioid receptor agonist".European Journal of Pharmacology.160 (2):229–37.doi:10.1016/0014-2999(89)90495-0.PMID 2547626.
  4. ^Kamei J, Tanihara H, Kasuya Y (October 1990). "Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats".European Journal of Pharmacology.187 (2):281–6.doi:10.1016/0014-2999(90)90014-w.PMID 2272363.
  5. ^Holtzman SG (July 2000). "Further characterization of the discriminative stimulus effects of spiradoline".Pharmacology, Biochemistry, and Behavior.66 (3):517–22.doi:10.1016/s0091-3057(00)00172-6.PMID 10899364.S2CID 27712517.
  6. ^Wadenberg ML (2003)."A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist".CNS Drug Reviews.9 (2):187–98.doi:10.1111/j.1527-3458.2003.tb00248.x.PMC 6741666.PMID 12847558.
Psychedelics
(5-HT2A
agonists)
Benzofurans
Lyserg‐
amides
Phenethyl‐
amines
2C-x
25x-NBx
25x-NB
25x-NB3OMe
25x-NB4OMe
25x-NBF
25x-NBMD
25x-NBOH
25x-NBOMe
Atypical structures
25x-NMx
N-(2C)-fentanyl
3C-x
4C-x
DOx
HOT-x
MDxx
Mescaline (subst.)
TMAs
Others
Piperazines
Tryptamines
alpha-alkyltryptamines
x-DALT
x-DET
x-DiPT
x-DMT
x-DPT
Ibogaine-related
x-MET
x-MiPT
Others
Others
Dissociatives
(NMDAR
antagonists)
Arylcyclo‐
hexylamines
Ketamine-related
PCP-related
Others
Adamantanes
Diarylethylamines
Morphinans
Others
Deliriants
(mAChR
antagonists)
Others
Cannabinoids
(CB1 agonists)
Natural
Synthetic
AM-x
CPx
HU-x
JWH-x
Misc. designer cannabinoids
D2agonists
GABAA
enhancers
Inhalants
(MixedMOA)
κORagonists
Oneirogens
Others
μ-opioid
(MOR)
Agonists
(abridged;
full list)
Antagonists
δ-opioid
(DOR)
Agonists
Antagonists
κ-opioid
(KOR)
Agonists
Antagonists
Nociceptin
(NOP)
Agonists
Antagonists
Others


Stub icon

Thishallucinogen-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Spiradoline&oldid=1203384352"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp